Results 191 to 200 of about 187,741 (262)

A thioacrylamide-based compound directly counteracts hepatic fibrosis with profound anti-obesity action. [PDF]

JHEP Rep
Rohbeck E, Niersmann C, Dewidar B, Köhrer K, Wachtmeister T, Guigas B, Lauschke VM, Ouwens DM, Roden M, Eckel J.   +9 more
europepmc   +1 more source

Pantothenic Acid Derivatives Modulate Oxidative Stress and Hepatic Fibrosis in Bile Duct Ligation-Induced Cholestatic Liver Injury. [PDF]

Pathophysiology
Semenovich DS, Abramicheva PA, Zorova LD, Elchaninov AV, Kozlova MA, Areshidze DA, Andrianova NV, Kanunnikova NP, Moiseenok AG, Pevzner IB, Plotnikov EY, Zorov DB.   +11 more
europepmc   +1 more source

Clonorchis sinensis excretory secretory products promote hepatic fibrosis through stimulating biliary epithelium to secrete IL-17A. [PDF]

PLoS Negl Trop Dis
Liu T, Gao H, Wang N, Wang W, Cao Z, Zhu H, Liu N, Gao H, Ji B, Liu T, Zhang F, Bai X.   +11 more
europepmc   +1 more source

F-53B exposure accelerates progression from preexisting fatty liver to non-alcoholic steatohepatitis and hepatic fibrosis. [PDF]

iScience
Hu C, Wu L, Zhang Z, Liu Y, Yang H, Zhou J, Wu Y, Wang Q.   +7 more
europepmc   +1 more source

Targeted delivery of lupeol via hyaluronic acid-modified ZIF-8 for anti-hepatic fibrosis therapy. [PDF]

Mater Today Bio
Liao B, Qin D, Hou R.
europepmc   +1 more source

Advances in pharmacological interventions for hepatic fibrosis: from pathogenic mechanisms to novel therapeutic targets. [PDF]

Ann Med
Zhang W, Shao T, Wang C, Wang S, An L.
europepmc   +1 more source

Gandouling protects against hepatic fibrosis in Wilson disease through the lncRNA-SNHG7/miR-29b/DNMT3A pathway. [PDF]

3 Biotech
Wang H, Sun L, Yin X, Hua D, Xuan Q, Wang J, Dong W, Yang W.   +7 more
europepmc   +1 more source

HMGB1-mediated enhancement of glycolysis activates hepatic stellate cells by inhibiting ferroptosis in alcoholic hepatic fibrosis. [PDF]

Stem Cell Res Ther
Li Y, Wang Q, Liao Z, Wu J, Yu S, Yan H, Xie Z.   +6 more
europepmc   +1 more source

Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Hawary OA, Wadie W, El-Said YAM, Hassan OF.   +3 more
europepmc   +1 more source